Hemaquest Pharmaceuticals, Inc.
Records under this name other than patents Hemaquest Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Hemaquest Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,857,152 | Methods and Compositions for Treating Viral or Virally-Induced Conditions Formerly held In force · Medium confidence | In force | Medium confidence | |
| US 12,083,119 | Methods and Compositions for Treating Viral or Virally-Induced Conditions Formerly held In force · Low confidence | In force | Low confidence | |
| US 8,759,378 | Methods for treating blood disorders Formerly held Lapsed on the fee record Ended Jun 24, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 24, 2026 | From the USPTO record |
| US 8,618,068 | Methods and Low Dose Regimens for Treating Red Blood Cell Disorders Formerly held Lapsed on the fee record Ended Dec 31, 2025 · High confidence | Lapsed on the fee record | Ended Dec 31, 2025 | High confidence |
| US 6,011,000 | Compositions for the treatment of blood disorders Formerly held Term ended Term ended Jan 4, 2017 · From the USPTO record | Term ended | Term ended Jan 4, 2017 | From the USPTO record |
| US 7,910,624 | Compositions for the treatment of blood disorders Formerly held Lapsed on the fee record Ended Mar 22, 2015 · From the USPTO record | Lapsed on the fee record | Ended Mar 22, 2015 | From the USPTO record |